tryptophan has been researched along with unipr129 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barocelli, E; Giorgio, C; Hassan-Mohamed, I; Incerti, M; Lodola, A; Mor, M; Pala, D; Pasquale, EB; Rivara, S; Russo, S; Tognolini, M; Vicini, P; Zanotti, I | 1 |
| Barocelli, E; Bugatti, A; Gioiello, A; Giorgio, C; Hassan-Mohamed, I; Incerti, M; Lodola, A; Mor, M; Pala, D; Rusnati, M; Russo, S; Tognolini, M; Vacondio, F | 1 |
| Barocelli, E; Callegari, D; Castelli, R; Giorgio, C; Incerti, M; Lodola, A; Pala, D; Rivara, S; Russo, S; Tognolini, M; Vacondio, F; Vicini, P; Zanotti, I | 1 |
| Ballabeni, V; Barocelli, E; Callegari, D; Chiodelli, P; Corrado, M; Ferlenghi, F; Giorgio, C; Incerti, M; Lodola, A; Rusnati, M; Russo, S; Tognolini, M | 1 |
4 other study(ies) available for tryptophan and unipr129
| Article | Year |
|---|---|
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations.
Topics: Angiogenesis Inhibitors; Apoptosis; Cell Cycle; Cell Line, Tumor; Ephrin-A1; Human Umbilical Vein Endothelial Cells; Humans; Lithocholic Acid; Molecular Docking Simulation; Neovascularization, Physiologic; Receptor, EphA2; Receptor, EphB4; Receptors, Vascular Endothelial Growth Factor; Tryptophan | 2014 |
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis.
Topics: Cell Line, Tumor; Chemical Phenomena; Humans; Lithocholic Acid; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Secondary; Receptor, EphA2; Structure-Activity Relationship; Surface Plasmon Resonance; Tryptophan | 2016 |
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.
Topics: Animals; Computer Simulation; Drug Design; Drug Stability; Ligands; Lithocholic Acid; Male; Mice; Microsomes, Liver; Models, Chemical; Molecular Docking Simulation; Protein Binding; Receptor, EphA2; Structure-Activity Relationship; Tryptophan | 2017 |
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.
Topics: Animals; Biological Availability; Cell Line, Tumor; Chick Embryo; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Ephrins; Humans; Lithocholic Acid; Protein Binding; Tryptophan | 2018 |